NCT01809158View on ClinicalTrials.gov

Minocycline for Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Schizophrenia
Interventions
DRUG

minocycline

DRUG

placebo

Trial Locations (1)

Unknown

Amanuel Psychiatric Hospital, Addis Ababa

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Addis Ababa University

OTHER

NCT01809158 - Minocycline for Schizophrenia | Biotech Hunter | Biotech Hunter